NCT03078738 - Safety and Pharmacokinetic Study of OMT-28 in Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 8, 2017

Primary Completion Date

March 12, 2018

Study Completion Date

March 12, 2018

Conditions

Healthy Volunteers

Interventions

DRUG

OMT-28

OMT-28 is a fully synthetic small molecule that belongs to the family of 17,18-epoxyeicosatetraenoic acids (17,18-EEQ) analogs, a natural metabolite of the omega-3 fatty acid eicosapentaenoic acid (EPA).

OTHER

Matching Placebo

Microcrystalline cellulose

Trial Locations (1)

Unknown

CRS-Mönchengladbach, Mönchengladbach